Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease
about
Biochemical and hematological findings of Khorasan veterans 23 years after sulfur mustard exposureImproving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseChronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.Characterization of sputum biomarkers for asthma-COPD overlap syndromeHealth-related quality of life of chemical warfare victims: an assessment with the use of a specific tool.Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.Mustard vesicant-induced lung injury: Advances in therapy.The effects of atorvastatin on mustard-gas-exposed patients with chronic obstructive pulmonary disease: A randomized controlled trial.Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysisDevelopment of a Fuzzy Decision Support System to Determine the Severity of Obstructive Pulmonary in Chemical Injured Victims.The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard.The role of serum level of interleukin-6 in severity of pulmonary complications of sulfur mustard injuries.Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway.Metabolomics diagnostic approach to mustard airway diseases: a preliminary study.Association of glutathione S-transferase polymorphisms with the severity of mustard lung.
P2860
Q28660444-44E354E5-11B8-4AC8-8B54-33ACC3E66494Q34511113-FEEB3FAC-88BD-40B3-AE93-CA4793E4E483Q36158231-ABBE8359-E65A-4C1B-AF66-F9E0CE2EB9DAQ36402823-EDCB5B68-9A6B-492E-BB95-D48C34546C6DQ37316797-84E56CD8-3696-4F96-B22D-6850B45E7A3CQ37640418-D959DC7D-34AF-4755-A350-8CE8E3216D4DQ38630989-01905143-525D-4741-8994-1EBD96D52E97Q38841450-D7EAB716-8688-4A48-870C-E3C701D1B1E5Q38965052-73564886-53DF-4FB0-8A63-CD8F4E38522EQ39410233-237084C6-8817-4EBF-8D8B-3E4C969956C8Q40667365-711BE8D2-210A-454E-8DBE-B6C9959F8476Q41869342-C4F9D18F-A0C1-4FCF-8682-7461BDF3AE9BQ42105003-25F7BB6C-5E18-467B-BDEA-01F830BE08CBQ47104691-7AEEBADF-7696-4A40-95C9-6736700CD136Q49243371-84E1EFC9-0B42-4E11-BD94-7CABA586A8BEQ49879325-0F77CAEE-2C7C-4EE8-A8C5-AA027BA0E8B8
P2860
Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@en
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@nl
type
label
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@en
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@nl
prefLabel
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@en
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@nl
P2093
P2860
P356
P1476
Interleukin-6 and airflow limi ...... obstructive pulmonary disease
@en
P2093
Davood Attaran
Hassan Ghobadi Marallu
Hossein Ayatollahi
Mohammad Khajehdaluee
Mohammad Towhidi
Mostafa Ghanei
Reza Basiri
Shahrzad M Lari
P2860
P304
P356
10.2147/COPD.S12545
P407
P577
2010-10-05T00:00:00Z